Hege Sagstuen Haugnes (Hege S Haugnes)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Patients Undergoing

Radical Prostatectomy

Papillary Thyroid

Top Venues

The Journal of urology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, Per-Olof Lundgren, Viktor Skokic, Bjarte Almås, Hege Sagstuen Haugnes, Torgrim Tandstad, Olof Akre, Gabriella Cohn-Cedermark, Olav Dahl, Anders Kjellman
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. The Journal of urology (2024)
Anna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, Per-Olof Lundgren, Viktor Skokic, Bjarte Almås, Hege Sagstuen Haugnes, Torgrim Tandstad, Olof Akre, Gabriella Cohn-Cedermark, Olav Dahl, Anders Kjellman
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. The Journal of urology (2024)
Anna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, Per-Olof Lundgren, Viktor Skokic, Bjarte Almås, Hege Sagstuen Haugnes, Torgrim Tandstad, Olof Akre, Gabriella Cohn-Cedermark, Olav Dahl, Anders Kjellman
miR-371a-3p Predicting Viable Tumor in Patients Undergoing RPLND for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. The Journal of urology (2024)
Einar Stikbakke, Tom Wilsgaard, Hege Sagstuen Haugnes, Mona Irene Pedersen, Tore Knutsen, Martin Støyten, Edward Giovannucci, Anne Elise Eggen, Inger Thune, Elin Richardsen
Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA- life Study. Cancers 14 (5) (2022)
Sophie D Fosså, Alv A Dahl, Lene Thorsen, Ragnhild Hellesnes, Cecilie E Kiserud, Torgrim Tandstad, Marianne Brydøy, Hege Sagstuen Haugnes, Tor-Åge Myklebust
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (23) (2022)
Ragnhild Hellesnes, Tor-Åge Myklebust, Sophie D Fosså, Roy M Bremnes, Ása Karlsdottir, Øivind Kvammen, Torgrim Tandstad, Tom Wilsgaard, Helene F S Negaard, Hege Sagstuen Haugnes
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (32) (2021)